This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,670,998 units of Ondansetron ODT 8 mg tablets, with a ceiling value of $13,863.34 and an ultimate completion date of December 11, 2024. The contract was awarded on December 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/11/25, 9:59 AM